Entrada Therapeutics, Inc.

Enterprise record · Agent view

Version public-1

Agent view

Machine access

Formats and access paths for the same published Governance Record shown in Human View.

alpha:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a · public-1

Published Claims: 20
Cited sources: 4
Record version: public-1

Formats

https://registry.alpha.ac/companies/entrada-therapeutics-inc.md

Open in new tabDownload

# Entrada Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/entrada-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 20 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-05T15:32:04.37995+00:00 |
| Last reviewed | 2026-10-05T15:32:04.37995+00:00 |

## Identity

- Legal name: Entrada Therapeutics, Inc.
- Display name: Entrada Therapeutics, Inc.

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Kush M. Parmar, M.D., Ph.D.: Board Chairman. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Bernhardt Zeiher: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Bernhardt Zeiher, M.D.: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Dipal Doshi: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Gina Chapman: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Kush M. Parmar: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:10. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Maha Radhakrishnan: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:11. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Maha Radhakrishnan, M.D.: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Mary Thistle: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:13. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Natarajan Sethuraman: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:14. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Peter S. Kim: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:15. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10.
- Peter S. Kim, Ph.D.: Director. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Dipal Doshi: Chief Executive Officer. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Kory Wentworth: Chief Financial Officer. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Natarajan Sethuraman: President of Research and Development. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:19. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dfdf49a67ffc219bcd56e6e351c41ff51388519e3c46af95ee69ce7dda55649e.
- Natarajan Sethuraman, Ph.D.: President of Research and Development. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.
- Nathan J. Dowden: President and Chief Operating Officer. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Entrada Therapeutics, Inc.. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d914e5c46b2bfd5958878df0b3fc8ff2dae148c214a78e51b5156fb302ef0c2c.

## Entity Status

- Public listing published. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d914e5c46b2bfd5958878df0b3fc8ff2dae148c214a78e51b5156fb302ef0c2c.

## Published Fact

- US. Claim: alpha:claim:company:994f0aa1-40ac-431e-a75c-0aa8be4df41a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d914e5c46b2bfd5958878df0b3fc8ff2dae148c214a78e51b5156fb302ef0c2c.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:d914e5c46b2bfd5958878df0b3fc8ff2dae148c214a78e51b5156fb302ef0c2c: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/entrada-therapeutics-inc).
- alpha:projection-evidence:document:648d8db272463e3265e31a0092b8f82d01c8d4ad1abf173486010126ecdec3c2: [SEC DEF 14A 0001689375-26-000021](https://www.sec.gov/Archives/edgar/data/1689375/000168937526000021/trda-20260424.htm).
- alpha:projection-evidence:document:6a34c49d1d9ce39d75239c37c4ae945dc8899135b3ff1d50c209dcf7c1683c10: [DEF 14A trda-20260424.htm](https://www.sec.gov/Archives/edgar/data/1689375/000168937526000021/trda-20260424.htm).
- alpha:projection-evidence:document:dfdf49a67ffc219bcd56e6e351c41ff51388519e3c46af95ee69ce7dda55649e: [TRDA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1689375/000168937526000021/trda-20260424.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/entrada-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/entrada-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/entrada-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/entrada-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/entrada-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

Connect

REST

MCP tools

Server card: Alpha Terminal · alpha://companies/entrada-therapeutics-inc

find_person
Search Alpha's permission-safe public Profile directory. Returns canonical Alpha person IDs, evidence-backed current roles, assurance state, review time, and limitations. Similar names remain separate candidates.
get_claim_evidence
Retrieve the public source evidence for one permissioned Alpha Profile claim. Returns source tier, URLs, validity, confidence, review time, and limitations.
get_company_profile
Retrieve a public Alpha Company Profile with canonical company identity, active listings, current confirmed board and executive roles, source evidence, explicit permissions, as-of time, and limitations. Private relationships, company administration, and unpublished ratings are excluded.
get_current_roles
Retrieve the current confirmed company and board roles from a public Alpha Profile. Every role includes available source evidence, confidence, verification state, and validity.
get_executive_profile
Retrieve a public Alpha Profile with canonical identity, current verified roles, permissioned claims, claim-level evidence, assurance state, as-of time, and limitations. Private contact, Council activity, and relationships are excluded.
get_platform_stats
Get Alpha platform statistics and data coverage. Returns counts of companies, directors, ratings, filings, and regulations in the Alpha intelligence database.

A2A

Agent card

Follow

Recent Registry updates (general index)

Record-specific changes feed and webhook events: Proposed. No delivery endpoint is published for this record.

Cite

URL: https://registry.alpha.ac/companies/entrada-therapeutics-inc
Version: public-1
JSON content hash: Unavailable

Evidence sources

Alpha canonical company public projection
SEC DEF 14A 0001689375-26-000021
DEF 14A trda-20260424.htm
TRDA DEF 14A executive officers